Nuwiq 250 IE

Nuwiq 250 IE is a medicine authorised by Swissmedic under authorisation number 65551. The authorisation holder is Octapharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 May 2016 and the authorisation is valid without a time limit. ATC code B02BD02 places the medicine in the group Antihemorrhagics.

  • Dispensing category B
  • Authorisation number 65551
  • ATC B02BD02
  • Biotechnological medicines
Authorisation data
Authorisation number65551
NameNuwiq 250 IE
Full nameNuwiq 250 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderOctapharma AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeB02BD02
First authorisation26 May 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Nuwiq 250 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB26 May 2016
2Nuwiq 500 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB26 May 2016
3Nuwiq 1000 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB26 May 2016
4Nuwiq 2000 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungB26 May 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11SetB02BD0206.01.1.B
21SetB02BD0206.01.1.B
31SetB02BD0206.01.1.B
41SetB02BD0206.01.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Nuwiq 250 IE authorised in Switzerland?

Yes. Nuwiq 250 IE is authorised by Swissmedic under authorisation number 65551, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Nuwiq 250 IE have?

Nuwiq 250 IE is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Nuwiq 250 IE?

The authorisation holder is Octapharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com